However, while current evidence supports the use of KIM-1 as a promising new avenue for the detection of AKI, concentrations may be affected by a variety of additional factors including the type of assay, timing and clinical setting of the sample collection, and patient age (46). This evidence concerns the gene HAVCR1 and acute kidney injury.